| Financial Year |
March 31 2023 |
| Monetary Funds |
230,888,427.72 |
| Held-for-trading Financial Assets |
395,000,000.00 |
| Notes Receivable |
10,973,119.05 |
| Accounts Receivable |
485,665,535.69 |
| Advances to Suppliers |
99,472,537.55 |
| Other Receivables |
48,762,630.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,759,350.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
72,370,389.53 |
| Other Current Assets |
29,814,972.25 |
| Total Current Assets |
2,744,211,364.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
48,956,166.34 |
| Long-term Equity Investment |
416,542,150.29 |
| Investment Properties |
138,913,887.00 |
| Fixed Assetes |
663,606,031.46 |
| Under-construction Projects |
37,009,944.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,873,242.16 |
| R&D expenses |
-- |
| Goodwill |
368,617,357.08 |
| Long-Term Deferred and Prepaid Expenses |
16,453,362.50 |
| Deferred Income Tax Assets |
72,988,026.43 |
| Other Non-Current Assets |
2,281,307.62 |
| Sub-Total of Non-Current Assets |
2,010,789,888.07 |
| Total Assets |
4,755,001,252.66 |
| Short-Term Loans |
1,023,382,684.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
647,650,111.94 |
| Accounts Received In Advance |
1,650,345.10 |
| Employee Compensation Payable |
61,909,442.75 |
| Taxes Payable |
27,399,285.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
188,457,116.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
428,469,786.97 |
| Other Current Liabilities |
56,527,999.87 |
| Sub-Total of Current Liabilities |
2,488,852,123.60 |
| Long-term Loans |
177,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
27,311,978.87 |
| Special Payable |
-- |
| Estimatied Liabilities |
139,914,271.08 |
| Deferred Income Tax Liabilities |
813,909.32 |
| Other Non-Current Liabilities |
103,984,081.11 |
| Sub-Total of Non-Current Liabilities |
467,918,071.00 |
| Total Liabilities |
2,956,770,194.60 |
| Paid-In Capital(Or Share Stock) |
715,197,812.00 |
| Capital Surplus |
1,774,080,071.64 |
| Surplus Reserve |
186,444,559.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,048,556,330.22 |
| Minority Stockholder's Interest |
169,434,318.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,628,796,739.69 |
| Owner's Equity（Stockholder's Equity） |
1,798,231,058.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,755,001,252.66 |
